Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Prader Willi Syndrome
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 92 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04283578
- Collaborators
- International Clinical Trials Association
- Epidemiological and Clinical Research Information Network
- Investigators
- Principal Investigator: Maithé TAUBER, MD University Hospital, Toulouse
Get Well Soon